Company is engaged by entities receiving the conditional approvals to professionally manage all 8 cultivation facilities; Company goes 8 for 8 on provisional cultivation license approvals

Medbox, Inc. (OTCQB:MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, today announced it’s clients were awarded 8 cultivation provisional license approvals in the state of Nevada.

The Company had filed 16 dispensary and cultivation center applications in the state on behalf of its clients and influential individuals in Nevada who have been appointed to the future dispensaries’ and cultivation centers’ board of directors. All applicants have engaged Medbox Management Services, Inc, a wholly owned Medbox subsidiary, to provide ongoing management services. The Company is in the process of identifying qualified state-screened 3rd party operators that will assume operations with professional oversight being provided by the Company. The Company has received provisional approval on all 8 licensing applications filed for cultivation centers and awaits additional information on its pending dispensary applications.

“Medicine will be in high demand in Nevada since the state will be allowing out-of-state patients to purchase the medicine,” commented Matthew Feinstein, VP at Medbox. “This is exciting news because it emphasizes Medbox Management Service’s entry into oversight and advisory services on the production side of the canna-business. This also allows our clients to utilize our patented seed-to-sale system to document compliance with state regulations more effectively.”

About Medbox, Inc:

Medbox (http://www.medbox.com) is the leading dispensary infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Headquartered in Los Angeles, CA, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning line of medical vaporizer products. Medbox, through its newly established subsidiaries, is also developing ancillary services tailored to the alternative medicine industry, including real estate acquisitions and subsequent lease programs to alternative medicine dispensaries and cultivation centers, and alternative medicine dispensary and cultivation management services.

Forward-Looking Statements:

Statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Investor RelationsStephen HartHayden IR917-658-7878hart@haydenir.comorMedia RelationsJackie Herskovitz RussellTeak Media + CommunicationsO: 617-269-7171jackie@teakmedia.com@TeakMediaorMedbox:For more information on Medbox, please call (800) 762-1452.